Table 1: Profile of participants and results of serological analysis.
Seroprevalence, n (%) |
|||||
|
Total |
Non Reagent |
IgM + |
IgG + |
IgM e IgG + |
Sample |
1015 (100) |
605 (59.6) |
96 (9.4) |
188 (18.5) |
127 (12.5) |
Gender |
|
|
|
|
|
Male |
597 (58.8) |
353 (59.1) |
56 (9.4) |
107 (17.9) |
81 (13.6) |
Female |
418 (41.2) |
252 (60.3) |
39 (9.3) |
81 (19.4) |
46 (11) |
Age, years |
|
|
|
|
|
18-29 |
375 (37) |
210 (56.1) |
40 (3.9) |
70 (6.9) |
55 (5.4) |
30-49 |
532 (52.4) |
322 (60.8) |
47 (4.6) |
100 (9.9) |
61 (6) |
50-69 |
108 (10.6) |
71 (65.8) |
8 (0.8) |
18 (1.8) |
11 (1.1) |